Future Directions for Process Development

Cell Therapy Symposium in Collaboration with Proteintech

RoslinCT was proud to collaborate with Proteintech on their recent virtual symposium, “Cell Therapy Symposium: Future Directions for Process Development.” This event brought together experts from across the cell and gene therapy field to explore critical topics in process development, scalability, and clinical translation.
Watch the full recording to hear insights from industry leaders – including RoslinCT- as they discuss the challenges and opportunities shaping the next generation of cell therapies.

Speakers:

Keynote Speaker: Dr. Catherine Tomaro-Duchesneau, Senior Director of Manufacturing MS&T at RoslinCT

Translating Potential: CDMO Perspectives on Bridging Discovery and Scalable Cell Therapy Manufacturing

Sofia Castelli, PhD Candidate at the University of Pennsylvania

IL-9 Redirects CAR T Cell Fate, Enhancing Efficacy Against Solid Tumors

Dr. Johanna Chiffelle, Postdoc at Lausanne University and Ludwig Research Institute

Comprehensive profiling and dynamics of tumor-reactive T cells at steady-state and during immunotherapy

Dr. Keerthana Ramanathan, Postdoc at The Technical University of Denmark

Generation of efficacious genetically engineered CAR- and TCR-T cells using antigen specific nano-scaffold-mediated expansion